Health Care • Medical/Nursing Services
$13.26 ▲ +0.20
(+1.53%)
MKT CAP: $2.89B • VOL: 2.33M
52W L $6 52W H $15
AVAH // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-03 | FY 2024
FILED 2024-12-28 | FY 2023
FILED 2023-12-30 |
|---|---|---|---|
| Revenue (Total Sales) | $2.43B | $2.02B | $1.90B |
| YoY Revenue Growth % | +20.2% | +6.8% | — |
| Gross Profit | $810.5M | $635.5M | — |
| Gross Margin % | 33.3% | 31.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $256.5M | $139.8M | $8.1M |
| Operating Margin % | 10.5% | 6.9% | 0.4% |
| Net Income (GAAP) | $225.0K | -$10.9K | -$134.5K |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $125.9M | $32.6M | $22.7M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $125.9M | $32.6M | $22.7M |
| FCF Margin % | 5.2% | 1.6% | 1.2% |
| Return on Invested Capital (ROIC %) | 15.7% | 10.4% | — |
| Cash & Short-Term Equivalents | $193.3M | $84.3M | — |
| Total Debt (Short + Long Term) | $1.29B | $1.27B | — |
| Total Stockholders' Equity | $194.5M | -$123.6M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR AVAH.